Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Receives CLIA Certification, Massachusetts Licensure for Clinical Sequencing

NEW YORK (GenomeWeb News) – Beckman Coulter said after the close of the market on Tuesday that it has received CLIA certification and Massachusetts State Licensure, allowing its genomics operations to begin accepting clinical samples for genetic sequencing.

As a result, Beckman Coulter Genomics will be able to provide sequencing results to doctors for the treatment, diagnosis and prevention of disease in patients, it said.

Beckman said that the certification "paves the way" for the detection of BRAF exon 11 and exon 15 for mutations using PCR-based DNA Sanger sequencing. The assay is the firm's first clinical molecular diagnostic assay. Beckman, a Danaher company, added that it plans to develop additional CLIA-certified assays using next-generation sequencing for oncology and infectious disease applications.

"This certification allows Beckman Coulter to work more closely with physicians to bring the promise of high quality molecular diagnostics to benefit greater numbers of patients," Joseph Repp, vice president and general manager of Beckman Coulter Genomics, said in a statement. "We're actively working to bring additional assays to physicians and clinical researchers across the country, as well as help all our customers further their understanding of genetic involvement in disease states."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.